The study shows YQTL activates PI3K-Akt, MAPK, and cAMP pathways concurrently, but doesn't explain whether this represents pathway crosstalk, compensation, or distinct therapeutic mechanisms. This knowledge gap limits understanding of the compound's systems-level neuroprotective strategy. Gap type: unexplained_observation Source paper: Elucidation of the mechanism of Yiqi Tongluo Granule against cerebral ischemia/reperfusion injury based on a combined strategy of network pharmacology, multi-omics and molecular biology. (None, None, PMID:37393828)
Landscape Summary: Why does YQTL activate multiple seemingly redundant neuroprotective pathways simultaneously? is a 0.73 priority gap in cerebrovascular. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why does YQTL activate multiple seemingly redundant neuroprotective pathways simultaneously? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: